VEGFA and cancer: Quite a few angiogenesis inhibitors for the treatment of cancer have been approved by FDA including Bevacizumab (targeting vascular endothelial growth factor, VEGF), Sorafenib (tyrosine kinase inhibitror, TKI), Sunitinib (TKI) et al. [53].